Nike Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Source: benzinga.com

Nike is expected to report fiscal first-quarter EPS of $0.44, down 10% from $0.49 a year earlier, on revenue projected at $11.34 billion versus $11.72 billion last year, a 3.2% decline. Analyst sentiment has deteriorated ahead of the Oct. 1 release: UBS, Telsey, Baird and Citigroup cut price targets, while Baird downgraded Nike to Neutral and Morgan Stanley reinstated an Underweight rating with a $31 target. Nike shares closed at $36.05, down 0.1%.
Analysis
The pre-print setup is unfavorable because estimate cuts and rating resets have likely shifted the debate from whether demand is soft to whether management can stabilize gross margin while rebuilding product momentum. A mere in-line result is unlikely to rerate NKE: the stock needs evidence that North America wholesale sell-through, China demand, and digital traffic are improving without incremental markdowns. The key sensitivity is forward guidance and gross-margin trajectory, not the reported EPS number; another reset to fiscal-year margin or revenue assumptions could compress the equity toward the low-$30s, where the bear-case target cluster sits.
Competitive read-through is asymmetric. Continued Nike promotional activity would pressure brand pricing and retailer inventory discipline, negatively affecting Foot Locker (FL) and DICK'S Sporting Goods (DKS) through lower footwear ASPs and potentially more cautious orders. Conversely, sustained category-share gains by premium challengers such as Deckers (DECK), On Holding (ONON), and Lululemon (LULU) would indicate that Nike's issue is brand/product execution rather than a broad athletic-demand slowdown; that distinction matters because a macro rebound alone would not repair NKE's multiple.
Near term, implied volatility into earnings may price a larger move than the fundamental informational value if expectations have already been broadly de-risked. The contrarian bull case is that low expectations allow a relief rally on clean inventory, disciplined promotions, and unchanged forward targets; however, that rally is unlikely to persist beyond 1-3 months without independently visible improvement in wholesale orders and full-price sell-through. Falsify the bearish view if management guides to sequential gross-margin expansion, reports improving North America and China trends, and indicates that product-launch cadence is generating measurable demand rather than merely retailer replenishment.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately negative
Sentiment Score
-0.42
Ticker Sentiment
Key Decisions for Investors
- Maintain an underweight/short NKE through the Oct. 1 print only if options-implied downside is not already excessive; target a move toward $31-33 over 1-3 months on margin or guidance disappointment, with a stop on a close above $42 following credible full-year guidance stabilization.
- Prefer a relative-value pair: long ONON or DECK versus short NKE over 3-6 months. This isolates share-gain and premium-product execution from broad discretionary demand; exit if Nike demonstrates two consecutive quarters of full-price growth and gross-margin recovery, or if challenger brands guide to slowing wholesale sell-through.
- Watch FL and DKS as secondary shorts only if Nike signals elevated promotional intensity or incremental wholesale inventory clearance. The required missing confirmation is retailer-specific inventory/order commentary; absent that, do not initiate because both names can benefit from traffic and category replenishment despite Nike-specific weakness.
- For a defined-risk event expression, consider NKE put spreads expiring 1-2 months after earnings rather than outright puts, structured around $36/$31 strikes if pricing is favorable. The thesis requires a post-print estimate-reset catalyst; cap premium at an amount justified by a roughly 2:1 payout-to-premium profile.
More News
- Meta nears first new high in a year as Muse success showcases winning AI strategy
- Micron Stock Gets a Big Wall Street Boost Ahead of Earnings
- Imax is a must for movie theaters, making the stock a buy, Morgan Stanley says
- CRH stock hits 52-week low at 83.65 USD
- Meta’s Muse: who are the winners and losers of more agentic AI adoption?
- BofA Securities reiterates Buy on Meta stock, $810 price target